Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Castle Biosciences Inc (CSTL)

Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Castle Biosciences Inc 505 S. Friendswood Drive Suite 401 Friendswood TX 77546 USA

https://castlebiosciences.com Employees: 761 P: 866-788-9007

Sector:

Medical

Description:

Castle Biosciences Inc. is a commercial-stage dermatological cancer company. It is focused on providing physicians and patients, clinically actionable genomic information. Castle Biosciences Inc. is based in Texas, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,167,851
Enterprise Value, $K 1,058,171
Shares Outstanding, K 29,189
Float, K 27,292
% Float 93.50%
Short Interest, K 1,508
Short Float 5.17%
Days to Cover 5.28
Short Volume Ratio 0.25
% of Insider Shareholders 6.50%
% of Institutional Shareholders 92.60%

Financials:

Annual Sales, $ 332,070 K
Annual Net Income, $ 18,250 K
Last Quarter Sales, $ 83,040 K
Last Quarter Net Income, $ -500 K
EBIT, $ 1,970 K
EBITDA, $ 11,280 K

Growth:

1-Year Return 59.47%
3-Year Return 50.19%
5-Year Return -49.46%
5-Year Revenue Growth 540.20%
5-Year Earnings Growth 176.54%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.02 on 11/03/25
Next Earnings Date 02/26/26
Earnings Per Share ttm 0.25
EPS Growth vs. Prev Qtr -113.33%
EPS Growth vs. Prev Year -125.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CSTL Ratios

Ratio
Price/Earnings ttm 163.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 1.73%
Return-on-Assets % 1.47%
Profit Margin % 5.50%
Debt/Equity 0.02
Price/Sales 3.41
Price/Cash Flow 41.42
Price/Book 2.55
Book Value/Share 16.00
Interest Coverage 38.17
60-Month Beta 1.06
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar